[HTML][HTML] Position paper on the diagnosis and treatment of peripheral arterial disease (PAD) in people with diabetes mellitus

B Balletshofer, W Ito, H Lawall, N Malyar… - Experimental and …, 2019 - thieme-connect.com
This position paper is based on the current German and international guideline
recommendations [1][2][3] and serves as a short, clinically-oriented guideline for the …

A primer on cohort studies in vascular surgery research

M Kabeil, R Gillette, E Moore, RF Cuff, J Chuen… - Seminars in Vascular …, 2022 - Elsevier
Vascular research questions can be answered using various study designs. Observational
studies are used frequently to address a wide range of clinical questions when randomized …

Survival and causes of death among veterans with lower extremity revascularization with paclitaxel‐coated devices: insights from the veterans health administration

JA Gutierrez, SV Rao, WS Jones… - Journal of the …, 2021 - Am Heart Assoc
BACKGROUND The long‐term safety of paclitaxel‐coated devices (PCDs; drug‐coated
balloon or drug‐eluting stent) for peripheral endovascular intervention is uncertain. We used …

Editor's Choice–Real World Study of Mortality After the Use of Paclitaxel Coated Devices in Peripheral Vascular Intervention

J Mao, A Sedrakyan, PP Goodney, M Malone… - European Journal of …, 2023 - Elsevier
Objective This observational cohort study examined outcomes after peripheral vascular
intervention (PVI) with paclitaxel coated devices (PCD) and non-PCD, and evaluated …

[HTML][HTML] Towards uniform case-identification criteria in observational studies on peripheral arterial disease: A scoping review.

N Keekstra, M Biemond, J van Schaik… - Annals of Vascular …, 2024 - Elsevier
Objective The diagnosis peripheral arterial disease (PAD) is commonly applied for
symptoms related to atherosclerotic obstructions in the lower extremity, though its clinical …

[HTML][HTML] No increase in all-cause mortality at 2 years among patients undergoing drug-coated balloon angioplasty

EH Weissler, L Zepel, M Greiner, BG Hammill… - Cardiovascular …, 2020 - jacc.org
2. Teramoto T, Tsuchikane E, Matsuo H, et al. Initial success rate of percutaneous coronary
intervention for chronic total occlusion in a native coronary artery is decreased in patients …

Paclitaxel-coated devices in the treatment of femoropopliteal stenosis among patients≥ 65 years old: An ACC PVI Registry Analysis

EH Weissler, A Annapureddy, Y Wang… - American heart …, 2021 - Elsevier
Background The connection between paclitaxel-coated devices (PCD) use during
peripheral vascular interventions (PVI) and mortality is debated. We aimed to analyze …

[HTML][HTML] Outcomes of treatment with paclitaxel-coated devices for peripheral arterial disease

TI Kim, G Kiwan, A Mohamedali, Y Zhang… - Journal of Vascular …, 2021 - Elsevier
Objective The treatment of femoropopliteal peripheral artery disease (PAD) using paclitaxel-
coated devices (PCDs) has been shown to improve patency in several randomized trials …

[HTML][HTML] Adverse events in primary percutaneous coronary angioplasty with drug-eluting stents compared with drug-coated balloons: a retrospective outlook

HS Khan, J Malik, M Mohsin, A Javed, MU Farooq - Cureus, 2020 - ncbi.nlm.nih.gov
Adverse Events in Primary Percutaneous Coronary Angioplasty With Drug-Eluting Stents
Compared With Drug-Coated Balloons: A Retrospective Outlook - PMC Back to Top Skip to …

Positionspapier zur Diagnostik und Therapie der peripheren arteriellen Verschlusskrankheit (pAVK) bei Menschen mit Diabetes mellitus–Gemeinsame …

B Balletshofer, D Böckler, H Diener… - Diabetologie und …, 2020 - thieme-connect.com
Dieses Positionspapier basiert auf den aktuellen deutschen und internationalen
Leitlinienempfehlungen [1][2][3] und dient als kurze, klinisch orientierte …